Published in N Engl J Med on February 08, 1979
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child (1989) 3.76
Long survival in childhood lymphoblastic leukaemia. Br J Cancer (1987) 1.23
Long term survival and cure after childhood cancer. Arch Dis Child (1989) 1.22
Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. Br J Cancer (1984) 1.03
Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia. Br J Cancer (1979) 0.86
Current issues in the management of children with acute lymphocytic leukaemia. Postgrad Med J (1985) 0.83
Sex and acid phosphatase in childhood non-T lymphoblastic leukaemia. J Clin Pathol (1980) 0.82
Oral and dental considerations in pediatric leukemic patient. ISRN Hematol (2014) 0.77
Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am J Pathol (1999) 0.76
Acute leukemias in children. Can Fam Physician (1979) 0.75
Recent advances in haematology. Postgrad Med J (1981) 0.75
Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. CMAJ (1989) 0.75
Childhood acute lymphocytic leukemia: progress and problems in treatment. Can Med Assoc J (1981) 0.75
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med (1998) 5.20
Estimation of human body surface area from height and weight. Cancer Chemother Rep (1970) 4.17
Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med (2001) 3.98
Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1977) 3.97
Lung cancer. Lancet (2000) 3.93
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res (2001) 3.66
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med (1999) 3.53
Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud. Control Clin Trials (2000) 2.67
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol (2002) 2.42
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med (1995) 2.33
"Total therapy" studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer (1972) 2.28
A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer (1972) 2.25
Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood (1971) 2.18
Planning the size and duration of a clinical trial studying the time to some critical event. J Chronic Dis (1974) 2.11
Fatalities during remission of childhood leukemia. Blood (1972) 2.08
Extramedullary leukaemia. Clin Haematol (1978) 2.07
Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med (1993) 1.99
Prevention of central nervous system leukemia by irradiation. Cancer (1973) 1.96
Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med (1989) 1.69
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. N Engl J Med (1986) 1.67
Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials (1998) 1.60
The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med (1985) 1.59
Statistical reviewing policies of medical journals: caveat lector? J Gen Intern Med (1998) 1.56
Cessation of therapy during complete remission of childhood acute lymphocytic leukemia. N Engl J Med (1974) 1.55
Data monitoring committees and interim monitoring guidelines. Control Clin Trials (1999) 1.55
Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected]. Control Clin Trials (1993) 1.54
Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response. Cancer (1976) 1.53
Osteosarcoma: good news despite crude tools. J Clin Oncol (1992) 1.49
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42
Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood (1968) 1.40
Von Willebrand's disease: a comparative study of diagnostic tests. J Pediatr (1968) 1.39
Who are the homeless? Public Health (1994) 1.38
Childhood acute lymphocytic leukemia. Initial radiological bone involvement and prognosis. Am J Dis Child (1972) 1.36
Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (1992) 1.28
Statistics in medical journals: a survey of current policies and proposals for editors. Med Pediatr Oncol (1985) 1.27
An anomaly of neutrophil morphology with impaired function. N Engl J Med (1974) 1.23
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22
Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer (1975) 1.22
Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J Clin Invest (1967) 1.19
Comparison of two methods of preventing central nervous system leukemia. Blood (1973) 1.19
Drug effect in acute leukemia. J Clin Invest (1969) 1.18
A semiautomatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med (1967) 1.18
Nine years' experience with "total therapy" of childhood acute lymphocytic leukemia. Pediatrics (1972) 1.17
Meningococcemia associated with intravascular coagulation. Pediatrics (1967) 1.17
Blood coagulation in thyroid dysfunction. N Engl J Med (1965) 1.16
Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood (1982) 1.13
Therapy of localized and regional lymphosarcoma of childhood. Cancer (1971) 1.11
Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr (1981) 1.10
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet (1984) 1.10
Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses. Int J Hyperthermia (1999) 1.09
Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys (1993) 1.08
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials. J Clin Oncol (1995) 1.07
Childhood acute lymphocytic leukemia: study VIII. Cancer (1978) 1.07
Quality of survival in histiocytosis X: a Southwest Oncology Group study. Med Pediatr Oncol (1980) 1.07
The current status of the treatment of childhood acute lymphoblastic leukemia. Cancer Treat Rev (1976) 1.07
Response to combination therapy after relapse in childhood acute lymphocytic leukemia. Cancer (1972) 1.06
Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer (1977) 1.06
Characteristics of cell proliferation in four patients with untreated acute leukemia. Blood (1966) 1.06
Rearrangement of immunoglobulin heavy chain genes in T cell acute lymphoblastic leukemia. Blood (1985) 1.06
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia (2011) 1.05
Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958-1970. Cancer (1973) 1.05
New directions in the treatment of acute lymphoblastic leukemia in children. N Engl J Med (1986) 1.04
Sequential therapy of acute leukemia in childhood. J Pediatr (1967) 1.04
Combined modality therapy of acute lymphocytic leukemia. Cancer (1975) 1.04
An exploratory study of environmental and medical factors potentially related to childhood cancer. Med Pediatr Oncol (1991) 1.04
The natural history of colorectal carcinoma in adolescents. Cancer (1982) 1.02
The treatment of acute lymphoblastic leukaemia. Br J Haematol (1980) 1.01
The unmet needs of young people who have had a stroke: results of a national UK survey. Disabil Rehabil (2002) 1.01
Five years after central nervous system irradiation of children with leukemia. Int J Radiat Oncol Biol Phys (1976) 1.00
Detecting treatment-by-centre interaction in multi-centre clinical trials. Stat Med (2001) 1.00
Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood (1987) 1.00
Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer (2001) 0.98
Thrombopoiesis. Semin Hematol (1967) 0.98
In vitro determination of thymidine-3H labeling index in human solid tumors. Cancer Res (1974) 0.97
Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer (1975) 0.97
Cocaine-induced platelet defects. Stroke (1993) 0.96
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol (2004) 0.96
Non-Hodgkin's lymphoma in children. Br J Cancer Suppl (1975) 0.95
Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med (1969) 0.95
Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol (1980) 0.95
Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia. Cancer (1975) 0.94
Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study. Cancer (1975) 0.94